CellSource (4880) · RiskLower Provision Balance
Contract Loss on Contract Processing Services for Synovium-Derived Stem Cells
First written in FY2025. . Latest entry: FY2026-H1.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Provision for losses on an outsourced stem-cell processing contractA theme 1 companies write about · 1 as a headwind · 0 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2026-H1Lower Provision BalanceAnnual report
「Provision for contract losses under non-current liabilities decreased by ¥61.499 million」
Regarding the provision for contract losses related to contracted processing services for synovial-derived stem cells, the balance under non-current liabilities decreased by ¥61.499 million. The disclosure states that there has been no material change in the risk itself. - FY2025First statedAnnual report
「The contract loss provision was recognised based on the estimated amount equivalent to future licence fee payments related to the contract processing service for synovium-derived stem cells.」
A contract loss provision of ¥263.516 million was recognised, representing the estimated amount of future licence fee payments related to the contract processing service for synovium-derived stem cells. The filing states that additional recognition or reversal may occur due to unforeseeable changes in assumptions and other factors.